Post-earnings recap
Reported
Thu, Aug 3, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that 10X Genomics is facing challenges, as evidenced by the negative EPS surprise. The stock reacted slightly down by 0.36%, reflecting investor concerns about the company's performance and lack of guidance. Without clear revenue figures or future expectations, uncertainty remains high for investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.53 | N/A | -36.95% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed caution regarding future performance without offering specific guidance. They noted ongoing challenges in the current market environment.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company acknowledged challenges in meeting market expectations.